Orthopedics
Conference Coverage
Real-world data backs rivaroxaban for postop VTE prevention
Major finding: The 30-day VTE event rate was 0.47% for rivaroxaban and 0.81% for low molecular weight heparin (unadjusted RR, 0.58; P = .001).Data...
News
Epicondylitis, ACL repair helped by platelet-rich plasma
Conference Coverage
Bracing lessened patellofemoral pain in OA
Major finding: Patients who wore a patellofemoral brace over the course of 6 weeks had a significant reduction in patellofemoral pain as measured...
Conference Coverage
Knee replacement delayed by hyaluronic acid injections
Major finding: Patients with knee osteoarthritis who eventually underwent total knee replacement had their surgery delayed by a median 233 days if...
Conference Coverage
Orthopedic surgery among RA patients declining, study finds
Major finding: The incidence of any orthopedic surgery among rheumatoid arthritis patients declined from 94.6 per 1,000 person-years in 1998-2001...
Conference Coverage
Antirheumatic drugs don’t boost surgical infection risk
Major finding: Rheumatoid arthritis patients who remained on their antirheumatic medication while they underwent various types of surgery did not...
News
Orthopaedic surgeons’ ‘Choosing Wisely’ list centers on osteoarthritis treatments
News
FDA approves denosumab for giant cell tumors
News
Four factors predict likelihood of future knee replacement
Major finding: The best TKA prediction models included age, sex, BMI, and KOOS quality-of-life score, improving the AUC to 0.78 for the right knee...
News
Aspirin better than heparin at VTE prevention after total hip arthroplasty
Major finding: The primary efficacy outcome – development of symptomatic proximal DVT or PE during the 90 days after total hip arthroplasty –...
News
Osteoarthritis patients survive longer after hip resurfacing than replacement
Major finding: The number needed to treat with hip resurfacing to prevent 1 excess death was 29 when compared to cemented total hip replacement,...